[ET Net News Agency, 29 December 2023] FRONTAGE (01521) rose 9.5% to HK$2.3, breaking
above the 250-D SMA of HK$2.296.
It hits an intra-day high of HK$2.31, hitting an 1-month high, and an intra-day low of
HK$2.13. The total shares traded was 12.73 million, with a value of HK$28.07m. The active
buy/sell ratio is 90:10, with net buying turnover of HK$22.4m. CITIGROUP GLOBAL accounts
for greatest net responsive buying turnover of HK$101,476, with volume weighted average
price of HK$2.206. J.P. MORGAN BRO (HK) accounts for greatest net responsive selling
turnover of HK$13.48m, with volume weighted average price of HK$2.195.
Basic Information
=================
---------------------------------
Nominal 2.300 % Chg +9.52%
High 2.310 Low 2.130
Shares Tr 12.73m Turnover 28.07m
10-D SMA 2.140 %H.V 33.504
20-D SMA 2.104 VWAP 2.206
50-D SMA 2.053 RSI14 66.689
---------------------------------
Status: Breaking above the 250-D SMA, hitting an 1-month high, active buy/sell ratio is
90:10, with net buying turnover of HK$22.4m
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
FRONTAGE (01521) 2.30 +9.52
HUTCHMED (00013) 28.10 Unchanged
GENSCRIPT BIO (01548) 19.60 -0.91
INNOVENT BIO (01801) 42.55 +2.41
WUXI BIO (02269) 29.80 +3.11
TIGERMED (03347) 35.20 Unchanged
BEIGENE (06160) 109.30 -0.91
ZAI LAB (09688) 21.25 +2.16
AKESO (09926) 46.00 +1.43
REMEGEN (09995) 37.35 +2.19
---------------------------------------------
(ed)